These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 24698250)

  • 21. Coronary artery bypass graft surgery remains the standard of care for patients with diabetes.
    Moss E; Alam M; Ballantyne CM; Puskas JD
    Semin Thorac Cardiovasc Surg; 2013; 25(2):97-9. PubMed ID: 24216525
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of percutaneous coronary intervention with drug eluting stents versus coronary artery bypass grafting in patients with multivessel coronary artery disease: Meta-analysis of six randomized controlled trials.
    Fanari Z; Weiss SA; Zhang W; Sonnad SS; Weintraub WS
    Cardiovasc Revasc Med; 2015 Mar; 16(2):70-7. PubMed ID: 25662779
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outcome after coronary artery bypass surgery and percutaneous coronary intervention in patients with atrial fibrillation and oral anticoagulation.
    Gunn J; Kuttila K; Kiviniemi T; Ylitalo A; Biancari F; Juvonen T; Airaksinen KE
    Ann Med; 2014 Aug; 46(5):330-4. PubMed ID: 24813457
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Propensity analysis of long-term survival after surgical or percutaneous revascularization in patients with multivessel coronary artery disease and high-risk features.
    Brener SJ; Lytle BW; Casserly IP; Schneider JP; Topol EJ; Lauer MS
    Circulation; 2004 May; 109(19):2290-5. PubMed ID: 15117846
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is the Syntax score II and its principles behind it applicable to the entire spectrum of the real world practice?
    Parissis H
    Int J Cardiol; 2016 Jul; 214():13-5. PubMed ID: 27055159
    [No Abstract]   [Full Text] [Related]  

  • 26. Surgical versus percutaneous coronary revascularization for multivessel disease in diabetic patients with non-ST-segment-elevation acute coronary syndrome: analysis from the Acute Catheterization and Early Intervention Triage Strategy trial.
    Ben-Gal Y; Mohr R; Feit F; Ohman EM; Kirtane A; Xu K; Mehran R; Stone GW
    Circ Cardiovasc Interv; 2015 Jun; 8(6):. PubMed ID: 26019142
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Meta-analysis of percutaneous coronary intervention versus coronary artery bypass graft surgery in patients with diabetes and left main and/or multivessel coronary artery disease.
    Gao F; Zhou YJ; Shen H; Wang ZJ; Yang SW; Liu XL
    Acta Diabetol; 2013 Oct; 50(5):765-73. PubMed ID: 22907763
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Appraising failure of surgical and percutaneous revascularization: long term outcomes from an observational registry.
    D'Ascenzo F; Bollati M; Quadri G; Gonella A; Di Cuia M; De Simone V; Colaci C; Reitano C; Vagnarelli M; Biondi Zoccai G; Moretti C; Sciuto F; Omedè P; Sheiban I; Gaita F
    Minerva Cardioangiol; 2013 Dec; 61(6):675-81. PubMed ID: 24253459
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Strategies for multivessel revascularization in patients with diabetes.
    Lee JH; Lee SW
    J Comp Eff Res; 2013 May; 2(3):231-4. PubMed ID: 24236622
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CABG or PCI for revascularisation in patients with diabetes?
    Kappetein AP; Head SJ
    Lancet Diabetes Endocrinol; 2013 Dec; 1(4):266-8. PubMed ID: 24622407
    [No Abstract]   [Full Text] [Related]  

  • 31. Incidence, correlates, and significance of abnormal cardiac enzyme rises in patients treated with surgical or percutaneous based revascularisation: a substudy from the Synergy between Percutaneous Coronary Interventions with Taxus and Cardiac Surgery (SYNTAX) Trial.
    Farooq V; Serruys PW; Vranckx P; Bourantas CV; Girasis C; Holmes DR; Kappetein AP; Mack M; Feldman T; Morice MC; Colombo A; Morel MA; de Vries T; Dawkins KD; Mohr FW; James S; Ståhle E
    Int J Cardiol; 2013 Oct; 168(6):5287-92. PubMed ID: 23993326
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improved survival in asymptomatic diabetic patients with high-risk SPECT imaging treated with coronary artery bypass grafting.
    Sorajja P; Chareonthaitawee P; Rajagopalan N; Miller TD; Frye RL; Hodge DO; Gibbons RJ
    Circulation; 2005 Aug; 112(9 Suppl):I311-6. PubMed ID: 16159837
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of Five-Year Outcome of Percutaneous Coronary Intervention With Coronary Artery Bypass Grafting in Triple-Vessel Coronary Artery Disease (from the Coronary Revascularization Demonstrating Outcome Study in Kyoto PCI/CABG Registry Cohort-2).
    Shiomi H; Morimoto T; Furukawa Y; Nakagawa Y; Tazaki J; Sakata R; Okabayashi H; Hanyu M; Shimamoto M; Nishiwaki N; Komiya T; Kimura T;
    Am J Cardiol; 2015 Jul; 116(1):59-65. PubMed ID: 25956622
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cost-effectiveness of percutaneous coronary intervention versus bypass surgery from a Dutch perspective.
    Osnabrugge RL; Magnuson EA; Serruys PW; Campos CM; Wang K; van Klaveren D; Farooq V; Abdallah MS; Li H; Vilain KA; Steyerberg EW; Morice MC; Dawkins KD; Mohr FW; Kappetein AP; Cohen DJ;
    Heart; 2015 Dec; 101(24):1980-8. PubMed ID: 26552756
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Evolution of Coronary Bypass Surgery Will Determine Its Relevance as the Standard of Care for the Treatment for Multivessel Coronary Artery Disease.
    Glineur D; Gaudino M; Grau J
    Circulation; 2016 Oct; 134(17):1206-1208. PubMed ID: 27777289
    [No Abstract]   [Full Text] [Related]  

  • 36. Long-term outcomes and comparison after conventional coronary artery bypass grafting for left main disease between patients classified as percutaneous coronary intervention recommendation classes II and III.
    Cho Y; Misumi T; Shimura S; Aki A; Furuya H; Odagiri S; Okada K; Ueda T
    Eur J Cardiothorac Surg; 2014 Mar; 45(3):431-7. PubMed ID: 23979988
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk profile and 3-year outcomes from the SYNTAX percutaneous coronary intervention and coronary artery bypass grafting nested registries.
    Head SJ; Holmes DR; Mack MJ; Serruys PW; Mohr FW; Morice MC; Colombo A; Kappetein AP;
    JACC Cardiovasc Interv; 2012 Jun; 5(6):618-25. PubMed ID: 22721656
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Coronary artery bypass grafting versus drug-eluting stents in multivessel coronary disease. A meta-analysis on 24,268 patients.
    Benedetto U; Melina G; Angeloni E; Refice S; Roscitano A; Fiorani B; Di Nucci GD; Sinatra R
    Eur J Cardiothorac Surg; 2009 Oct; 36(4):611-5. PubMed ID: 19394857
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Coronary artery bypass grafting vs percutaneous coronary intervention and long-term mortality and morbidity in multivessel disease: meta-analysis of randomized clinical trials of the arterial grafting and stenting era.
    Sipahi I; Akay MH; Dagdelen S; Blitz A; Alhan C
    JAMA Intern Med; 2014 Feb; 174(2):223-30. PubMed ID: 24296767
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Outcomes of coronary revascularization (percutaneous or bypass) in patients with diabetes mellitus and multivessel coronary disease.
    Hee L; Mussap CJ; Yang L; Dignan R; Kadappu KK; Juergens CP; Thomas L; French JK
    Am J Cardiol; 2012 Sep; 110(5):643-8. PubMed ID: 22632829
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.